Sung Lee

CIK 1793200 · EVP, Chief Financial Officer · last filed 2026-06-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$6.01M

Companies

4

Total Filings

18

Lifetime Open-Market Net

-$2.20M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TNGX Director 22,870 $30.94 $707.6K $0 3 2026-06-08
CYTK EVP, Chief Financial Officer 63,221 $70.15 $4.43M -$2.14M 9 2026-05-05
VIR EVP & Chief Financial Officer 100,492 $8.61 $865.2K -$59.4K 3 2024-03-28
SANGAMO THERAPEUTICS, INC (SGMO) Delisted EVP, Chief Financial Officer 88,708 $0.18 $15.8K $0 3 2020-11-30

Recent Filings · Page 2 of 2

18 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-12-05 CYTK Mixed +7,071 -$79.1K EDGAR
2024-06-03 CYTK Grant (A) +34,684 $0 EDGAR
2024-03-28 VIR Sell (S) −6,008 -$59.4K EDGAR
2024-02-26 VIR Grant (A) +40,000 $0 EDGAR
2023-03-29 VIR Grant (A) +66,500 $0 EDGAR
2020-11-30 SANGAMO THERAPEUTICS, INC (SGMO) Delisted Tax (F) −5,042 -$49.3K EDGAR
2020-02-26 SANGAMO THERAPEUTICS, INC (SGMO) Delisted Grant (A) +50,000 $0 EDGAR
2019-11-26 SANGAMO THERAPEUTICS, INC (SGMO) Delisted Grant (A) +43,750 $0 EDGAR
Showing 1118 of 18
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.